Detroit-based drug firm gets FDA approval for diabetes med Repaglinide Tablets USP
Caraco Pharmaceutical Laboratories Ltd. said it received tentative approval from the United States Food and Drug Administration for the company’s Abbreviated New Drug Application for Repaglinide Tablets USP. The Detroit-based generic drug company said Repaglinide works by lowering the blood glucose in patients with type 2 diabetes whose hyperglycemia can’t be controlled properly by diet [...]